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Abstract
Background: Continuous-flow culture models are one tool for studying complex interactions between members of
human fecal microbiotas because they allow studies to be completed during an extended period of time under
conditions where pH, nutrient availability, and washout of waste products and dead cells can be controlled. Because
many of the existing well-validated continuous-flow models are large and complex, we were interested in developing
a simpler continuous-flow system that would allow microbial community dynamics to be examined in higher
throughput while still maintaining complex microbial communities. To this end, we developed minibioreactor arrays
(MBRAs), small volume bioreactors (15 ml) that allow simultaneous cultivation of up to 48 microbial communities in a
single anaerobic chamber.
Results: We used MBRA to characterize the microbial community dynamics of replicate reactors inoculated from three
different human fecal donors and reactors seeded with feces pooled from these three donors. We found that MBRA
could be used to efficiently cultivate complex microbial communities that were a subset of the initial fecal inoculum
(15–25 % of fecal OTUs initially observed). After an initial acclimation period of approximately 1 week, communities in
each reactor stabilized and exhibited day-to-day variation similar to that observed in stable mouse fecal communities.
Replicate reactors were predominately populated by shared core microbial communities; variation between replicate
reactors was primarily driven by shifts in abundance of shared operational taxonomic units (OTUs). Consistent with
differences between fecal donors, MBRA communities present in reactors seeded with different fecal samples had
distinct composition and structure.
Conclusions: From these analyses, we conclude that MBRAs can be used to cultivate communities that recapitulate
key features of human fecal communities and are a useful tool to facilitate higher-throughput studies of the dynamics
of these communities.
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Background
The gastrointestinal microbiome plays an important role
in health and disease (reviewed in [1–8]). Although
many insights about the role of the microbiota have
been gained by studying microbial community associ-
ation with the human host (e.g., [9–11]), the availability
of less complex models of the microbiota (i.e., conven-
tional and humanized animal ([12–16] and in vitro
models [17–22]) have also played an important role in
elucidating the roles of the microbiota.
Continuous-flow culture models are beneficial for
studying the complex interactions between members of
the host microbiota in vitro because they allow for stud-
ies to be completed during an extended period of time
under conditions where pH, nutrient availability, and
washout of waste products and dead cells can be better
controlled (reviewed in [23–25]). Although there are sev-
eral well-studied and validated in vitro models of human
microbiota (e.g., Simulator of Human Intestinal Microbial
Ecosystem (SHIME, [21, 26, 27]), the TNO gastrointestinal
model (TIM-2, [19, 28]) and the three-stage compound
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continuous culture system [18, 20]), we were interested in
developing a simpler, higher-throughput continuous cul-
ture system for human fecal communities.
To this end, we developed minibioreactor arrays
(MBRAs, [29]). MBRAs were strips of six replicate
bioreactors (each with a 15-ml operating volume) that
were positioned on a 60-position magnetic stir plate.
Continuous-flow was controlled by two 24-channel
peristaltic pumps. Because of their relatively small size
and simplistic design, up to 48 reactors could be run
simultaneously in a single anaerobic chamber, thereby
reducing the time and cost needed to evaluate
multiple experimental perturbations to microbial
communities.
Previously, we demonstrated that fecal microbial com-
munities established in our MBRAs recapitulate one im-
portant aspect of healthy microbial communities—the
ability to resist colonization by Clostridium difficile unless
perturbed by antibiotics [29]. Further, these MBRA com-
munities revealed differences in physiology between C.
difficile epidemic strains that were supported by
experiments in a humanized microbiota mouse model
of C. difficile, providing additional support for the
applicability of this model [29].
These initial studies primarily focused on C. difficile
physiology in the context of disrupted MBRA communi-
ties and did not more broadly characterize the types of
communities that could be cultivated. A more thorough
characterization of the types of communities that could
be cultivated in unperturbed MBRA was needed to
evaluate the suitability of this platform for other studies
characterizing microbial community dynamics and func-
tion. Therefore, we followed changes in microbial com-
munity structure over time in replicate MBRAs
inoculated from three different fecal donors as well as
MBRAs inoculated from a pool composed of these three
donors.
We found distinct communities could be cultivated
from each donor. Community composition stabilized
within ~7 days of flow (~21 reactor turnovers based
upon the 8-h retention time of MBRAs) to contain a
core set of 40–45 operational taxonomic units (OTUs;
clustered with ≥97 % ANI across the V4 region of the
16S rRNA gene) across replicate reactors from the same
donor. These core set of OTUs contained ~65–95 % of
the total sequences. Cultivation resulted in restructuring
of the starting fecal communities, with modest decreases
in Firmicutes, Actinobacteria, and unclassified bacteria
coupled to increases in Bacteroides, Proteobacteria, and
Verrucomicrobia. From our studies, we conclude that
communities cultivated in MBRAs recapitulate key fea-
tures of human fecal microbiota and that MBRAs are a
useful tool to facilitate higher-throughput studies of the
dynamics of these communities.
Results and discussion
Diverse microbial communities can be cultivated in MBRA
We inoculated triplicate reactors with fecal samples
from one of three healthy donors (donor A, donor B, or
donor C) or six replicate reactors with an equal mass of
fecal sample pooled from each of the three donors
(pool). After an initial acclimation period (16 h), we
collected samples (day 1) and initiated continuous flow
operation of the reactors with an 8-h retention time. We
then collected samples from all communities daily for 20
additional days (days 2–21). We monitored changes in
microbial communities by amplifying and sequencing
the V4 region of the 16S rRNA gene from these samples
as well as from the initial fecal inocula (day 0). We then
quality-filtered the data and clustered the sequences into
OTUs with ≥97 % average nucleotide identities before
further analyses.
We found that cultivation in the MBRAs supported
growth of diverse microbial communities. Microbial di-
versity, as measured by either the Inverse Simpson Index
(Fig. 1a) or Shannon Index (see Additional file 1A for
graph), was similar between the starting fecal inocula
and the MBRA communities on days 2–21 in culture.
Cultivation resulted in a decrease of the overall number
of OTUs by approximately twofold relative to the start-
ing fecal inocula (Fig. 1b); this was primarily due to loss
of low abundance OTUs (OTUs with one sequence in
the fecal samples, see Additional file 1B for graph).
Consistent with a decrease in the number of low
abundance OTUs, the overall evenness of OTU distribu-
tion increased approximately two- to threefold in the
MBRA communities relative to the starting fecal inocula
(Fig. 1c).
We observed that both microbial diversity and even-
ness spiked on day 1, after 16 h of incubation in medium
and prior to the initiation of flow. This transient burst in
diversity and evenness likely reflects the unique nature
of the sample, which contained those community mem-
bers that had begun growing as well as those community
members that will not grow, either because they were
non-viable or could not be cultivated under these condi-
tions. (The method that we used to measure community
composition, amplification of the 16S rRNA gene, does
not distinguish live from dead cells.) However, once flow
was initiated, non-viable and non-growing strains were
lost by dilution and turnover within the MBRA, and the
remaining community members were those capable of
growth in the distinct MBRA communities.
MBRA cultivation impacts community composition and
structure
We next examined the impact of cultivation on the com-
position and structure of MBRA microbial communities.
We determined the relationships between communities
Auchtung et al. Microbiome  (2015) 3:42 Page 2 of 15
present in each sample using two similarity measures,
Bray-Curtis similarity (Fig. 2a; Bray-Curtis similarity = 1-
Bray-Curtis Dissimilarity), which calculates community
similarity as the ratio of sequences in shared OTUs to
total sequences, and Sorenson similarity (Fig. 2b; Sorenson
similarity = 1-Sorenson Dissimilarity), which calculates
community similarity as the ratio of shared to total OTUs
[30]. We visualized the relationships between samples
with non-metric multi-dimensional scaling (NMDS). As
anticipated from previous studies (e.g., [31]), each individ-
ual fecal community was distinct. Although cultivation
resulted in shifts in microbial composition compared to
the starting fecal inocula (discussed more below), MBRA
communities from each fecal donor (A, B, or C) rapidly
formed distinct communities (Fig. 2a, b), with significant
differences between communities inoculated from differ-
ent fecal donors present by day 2 in culture.
The significance of differences detected between com-
munities on days 2–21 were evaluated with two non-
parammetric tests of community similarity, analysis of
similarities (ANOSIM) [32] and PERMANOVA [33].
ANOSIM compares the rank similarities of samples
within and between groups, generating an R-statistic
varying from 1 (rank similarities within all replicates of a
group are more similar than rank similarities between
groups) to 0 (replicates within and between groups have
similar rank similarities). Statistical significance is deter-
mined by comparing the R-statistic to the null distribution
of R, which is calculated from iterations of randomly
permuted data. PERMANOVA evaluates difference in
community composition by calculating the differences
within and between groups based upon the sum of
squared distances from the centroid. The magnitude
of the differences within and between groups is
reflected in the pseudo-F value (F value >>1, reflects
increasing differences in community composition),
and the significance of this value is determined by
random permutation. Using both tests for differences
in community distributions, we observed that communi-
ties were separated with high significance (p = 0.001 based
upon 999 permutations) and that this separation was
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Fig. 1 Impact of MBRA cultivation on microbial diversity. Microbial
diversity of triplicate MBRA communities inoculated with one of
three donor fecal samples (Donor A, blue circles; Donor B, green
circles; Donor C, purple circles) or in six replicate MBRA communities
inoculated with an equal mass of all three donor fecal samples
(Pool, black circles) was determined by sequencing the V4 region of
the 16S rRNA gene from samples collected daily over 21 days in
culture. Microbial diversity (Inverse Simpson, a), total number of
OTUs (b), and evenness of OTU distribution (Simpson Evenness, c)
was calculated from OTUs (≥97 % average nucleotide identity (ANI))
that were randomly subsampled to 10,000 sequences over 100
iterations. The mean value for the replicate reactors as a function of
time in culture is plotted (day 0 = fecal inoculum; error bars
represent standard deviation of the mean)
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typically large (ANOSIM R values >0.89 and PERMA-
NOVA F-statistics >55, Table 1).
MBRA communities inoculated with the pooled samples
formed distinct communities. Comparison of differences
between the communities formed from the pooled fecal
sample to communities formed from donor A, B, or C also
demonstrated that the donor C communities were less
similar to the pooled communities than either donor A or
donor B communities. These data indicate that the a lar-
ger proportion of community members present in donor
C may not be able to compete with community members
present in donor A or B during cultivation in MBRA.
MBRA cultivation leads to stable microbial communities
Community stability can be challenging to define, as one
must decide how much variation is acceptable in a stable
community. One previously reported measure for stability
[34] that we applied to our data was to plot the mean
Bray-Curtis similarity for each day’s sample relative to all
other days in culture as a function of time in culture
(Fig. 3a). From this plot, we observed that mean similarity
values increased rapidly over the first 3 days in culture
(slope of line from day 0 to day 3, 0.13 ± 0.04 (mean ±
SD)), continued to increase at a reduced rate through day
7 (Slope of line from day 4 to day 7, 0.019 ± 0.01), and
plateaued around day 8 in culture (slope of line from day
8 to day 11, −0.009 ± 0.01). More precisely, the inflection
point of each curve (i.e., point where slope transitioned
from positive to negative) was identified by determining
the slopes of each line with three-point sliding windows;
the inflection point varied from day 8 to day 12, with a
median of 8 and a mean of 8.6. By day 8 in culture, com-
munities had experienced 7 days of continuous flow (~21
reactor turnovers with 8-h retention time). A second
measure of stability [35], calculating the similarity between
reactors as a function of increasing days in culture, dem-
onstrated similar stabilization dynamics (Fig. 3b).
To better resolve the differences in community struc-
ture in stable bioreactor communities, we re-calculated
the mean Bray-Curtis dissimilarity for each day’s sample
for days 8–21 and plotted this as a function of time
(see Additional file 2). We observed that the mean
Bray-Curtis similarities from day-to-day ranged from
0.58 to 0.86, with a mean of 0.74 ± 0.05.
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Fig. 2 Impact of MBRA cultivation on community composition and
structure. Using the data described in Figure 1, we determined
pairwise relationships between samples from MBRA communities
inoculated with different fecal samples and their respective fecal
inocula using (a) Bray-Curtis and (b) Sorenson dissimilarity measures
and plotted this data with non-metric multi-dimensional scaling.
Fecal samples = solid diamonds; MBRA communities = open symbols,
with replicate 1 = squares, replicate 2 = circles, replicate 3 = triangles,
replicate 4 = diamond, replicate 5 = inverted triangle, replicate 6 = asterisks;
donors A, B, C, and the pool = blue, green, purple, and black, respectively.
The stress for each NMDS plot is indicated
Table 1 Evaluation of variation between MBRA communities
inoculated with different fecal samples by analysis of similarities
(ANOSIM, [32]) and permutational multivariate analysis of
variance (PERMANOVA, [33])
Bray-Curtis similarity Sorenson similarity
ANOSIM
R-statistic
PERMANOVA ANOSIM
R-statistic
PERMANOVA
F value R2 F value R2
Donor A-donor B 0.94 89.5 0.44 0.9 54.8 0.32
Donor A-donor C 0.99 106.7 0.49 0.98 76.4 0.4
Donor B-donor C 0.99 115.0 0.5 0.93 61.6 0.35
Donor A-pool 0.58 40.9 0.19 0.65 35.1 0.17
Donor B-pool 0.57 48.8 0.21 0.74 39.2 0.18
Donor C-pool 0.97 106.9 0.38 0.9 68.8 0.28
All p values were 0.001 based upon 999 permutations
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Previous studies have shown that variations in sampling,
extraction, and sequencing can lead to introduction of
artificial variation among samples (e.g., [35, 36]). In order
to determine the amount of technical variation present in
our data, we performed duplicate sequencing of three
identical samples (described in the “Methods” section)
and analyzed as described above. We found that the mean
Bray-Curtis similarity between these technical replicates
was 0.87 ± 0.04 (Additional file 2, red line). Thus, the
mean variation in stable reactor communities was twice
that observed in technical replicates; this twofold difference
correlates to increased variation of sequence distribution
of ~13 % in stable reactor communities relative to
the controls.
Variation in microbial communities increases between
replicate reactors
Having identified the window in which communities
stabilize within each reactor (days 8–21), we next
wanted to examine how these communities varied across
replicates from the same fecal donor. We determined
the mean similarities between replicate reactors inocu-
lated from the same donor on days 8–21 and compared
this to the mean similarities observed within each
reactor from day-to-day on days 8–21 (Table 2). We
observed that Bray-Curtis similarities decreased ~1.7–
1.8-fold between replicate reactors. (Mean similarity
values ranged from 0.54 ± 0.07 to 0.61 ± 0.08.) This
divergence occurred primarily within the first 5 days of
cultivation and did not increase significantly once indi-
vidual reactors had stabilized (see Additional file 3 for
graph of similarities between replicate reactors over
time). In contrast, Sorenson similarity decreased ~1.1–
1.2-fold between replicate reactors (Table 1; mean simi-
larity values from 0.67 ± 0.04 to 0.70 ± 0.04). Although
these decreases in Bray-Curtis similarities were modest,
these data indicate that changes in the relative abun-
dance of shared OTUs is one potential mechanism that
led to differences between replicate reactors.
Comparison of variation in stable reactor communities to
stable mouse communities
To gauge how MBRA community variation compares
with another experimental model of gastrointestinal
community dynamics, we compared our data to that
published by Schloss and colleagues [37], who examined
fecal microbial community stabilization in mouse micro-
bial communities post-weaning. In this work, they
observed that mouse communities exhibited the greatest
variation in community structure in the first 9 days
post-weaning and that community structure had stabi-
lized by days 141–150 post-weaning. Therefore, we com-
pared community dynamics in our stable MBRA
communities (days 8–21) to differences in community
dynamics within each mouse from day-to-day and be-
tween different mice over time. Although these models
of GI community dynamics have several differences that
could impact community dynamics (murine vs human
microbiota; presence of host to provide different nutri-
ents, niches, and selection from immune system), we
were interested in examining the similarities and differ-
ences between community dynamics in these disparate
models. We found that community dynamics were quite
similar between mice and MBRAs.
Because their original work analyzed stability with a
different dissimilarity measure (θYC) and used data
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Fig. 3 Stabilization of MBRA microbial communities (a). MBRA
community stability was assessed by plotting the average Bray-Curtis
(BC) similarity between each daily bioreactor sample and other days
in culture as a function of time in culture. The point at which reactors
reached stability was defined as the inflection point of the curve and
varied from day 8–12 (median = day 8). b The mean Bray-Curtis similarity
(± standard deviation) for samples at increasing time intervals were
calculated for all reactors over the indicated time intervals (days 2–7
(transitioning communities) and days 8–13 (stable communities)) and
plotted as a function of days between samples. Statistical testing of each
time interval with an unpaired student’s t test demonstrated that the
differences in similarity observed between transitioning (days 2–7) and
stable (days 8–13) were significant (p≤ 0.03)
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generated by pyrosequencing the V3–V5 region of the
16S rRNA gene, we reanalyzed a subset of their data,
which was generated by Illumina sequencing of the V4
region and used to cross-validate a new dual-indexing
sequencing approach for community analyses [37], using
the methods described above. Further, as they observed
neither litter, co-housing status, nor sex of the mouse
significantly impacted community structure, we selected
data from three male and three female mice and treated
these mice as independent replicates for our analyses.
Day-to-day variation within each mouse
We calculated the mean Bray-Curtis similarity within
mice with stable communities to be 0.79 ± 0.06 (see
Additional file 4 for a table of mean dissimilarities in
stable and unstable mouse communities). Sorenson simi-
larity values were similar, with mean within mouse
values of 0.76 ± 0.04. From these data, we conclude that
stable individual MBRA communities exhibit similar
day-to-day variations as those found in stable murine
communities.
Variation between replicate mice
The variation in Bray-Curtis similarities between repli-
cate mice with stable communities was 0.71 ± 0.05 (see
Additional file 4), which is ~10–15 % lower than the
similarity observed between replicate reactors (0.54 ±
0.07 to 0.61 ± 0.08 to, Table 2). In contrast, the Sorenson
similarity values between replicate reactors (0.67 ± 0.04
to 0.70 ± 0.04, Table 2) and replicate mice (0.72 ± 0.04,
see Additional file 4) were similar.
One potential contributing factor to the higher variation
observed in replicate reactors is the higher abundance of
Firmicutes in MBRA communities compared to the
mouse communities (56 ± 13 % in MBRA; 28 ± 8 % in
mice). Flores et al. [38] examined temporal stability in
human fecal communities over time and found those
subjects that exhibited higher variation in community
structure over time also had a higher ratio of Firmi-
cutes/Bacteroidetes than those subjects with lower
variation in community structure. As is discussed in
more detail below, we found that the distribution of
OTUs belonging to the Firmicutes and Proteobacteria
phyla were more variable in our samples than OTUs
belonging to the Bacteroidetes.
Another possible contributing factor to the lower
variation observed in mouse data is that communities
colonizing these mice are highly adapted to co-
existence in the murine GI tract, where selection can
be imposed by interactions with host cells, other
members of the microbiota, and nutrients from the
host diet. In contrast, cultivation in MBRAs could
allow organisms with functional redundancy under
MBRA cultivation conditions to fluctuate stochastic-
ally during stabilization until stable communities are
reached.
Composition of core MBRA communities and comparison
to starting fecal inocula
To gain further insights into the composition and struc-
ture of MBRA communities, we identified those OTUs
that were conserved across samples (i.e., core communi-
ties). We identified core communities on three different
levels: OTUs found conserved from day-to-day over days
8–21 within each single reactor (individual core), OTUs
shared from day-to-day over days 8–21 between repli-
cate reactors of the same fecal donor (fecal type core),
and OTUs common to all reactor communities over
time (all MBRA core). We also compared the compos-
ition of these core communities to their starting fecal
inocula.
Table 2 Comparison of mean Bray-Curtis and Sorenson similarities for OTUs present in MBRA communities on days 8–21
Reactor
type
Within
reactora
Between
replicatesb
Between reactor typesc
A B C Pool
Bray-Curtis
Donor A 0.73 ± 0.08 0.54 ± 0.07 NA 0.29 ± 0.06 0.26 ± 0.05 0.47 ± 0.08
Donor B 0.79 ± 0.07 0.61 ± 0.08 0.29 ± 0.06 NA 0.25 ± 0.06 0.46 ± 0.10
Donor C 0.73 ± 0.10 0.55 ± 0.07 0.26 ± 0.05 0.25 ± 0.06 NA 0.32 ± 0.07
Pool 0.72 ± 0.09 0.57 ± 0.07 0.47 ± 0.08 0.46 ± 0.10 0.32 ± 0.07 NA
Sorenson
Donor A 0.74 ± 0.05 0.69 ± 0.04 NA 0.55 ± 0.05 0.52 ± 0.05 0.64 ± 0.04
Donor B 0.71 ± 0.05 0.67 ± 0.04 0.55 ± 0.05 NA 0.53 ± 0.05 0.61 ± 0.04
Donor C 0.73 ± 0.04 0.67 ± 0.04 0.52 ± 0.05 0.53 ± 0.05 NA 0.57 ± 0.04
Pool 0.74 ± 0.04 0.7 ± 0.04 0.64 ± 0.04 0.61 ± 0.04 0.57 ± 0.04 NA
aMean ± SD across all replicates of similarities within each replicate reactor of the indicated fecal type
bMean ± SD across all pairwise comparisons of similarities between replicate reactors of the same fecal type on days 8-21
cMean ± SD across all replicates of similarities between reactors of the different fecal types on days 8-21
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Identification of core communities
OTUs were designated as members of a core community
if they were present in at least 90 % of daily samples col-
lected from a single reactor between days 8–21. Using
these criteria, we found that the core communities
maintained from day-to-day within each reactor varied
from 55 to 72 OTUs (~50–60 % of total OTUs from
each day sampled; Fig. 4a (individual cores)). These indi-
vidual core OTUs contained 95–98 % of the sequences
from each day sampled (Fig. 4b). When we determined
the overlap between OTUs found in the core communi-
ties of replicate reactors of from the same fecal donor,
we found that the core community shared between rep-
licate reactors of the same fecal type was composed of
40–45 OTUs (~30–40 % of total OTUs, Fig. 4a (fecal
type core)) and contained 66–95 % of sequences present
in each reactor from each day sampled (Fig. 4b). Finally,
we determined the overlap in core membership across
MBRA replicates from all fecal types and found that this
all MBRA core contained 12 OTUs comprising 18–48 %
of total sequences from each reactor across every day
sampled (Fig. 4; also see Additional file 5 for a table list-
ing the 12 OTUs comprising the all MBRA core and
their abundances across samples).
Comparison of MBRA communities with fecal inocula
We also examined the phylogenetic distribution of
OTUs present in the MBRA core communities and
compared this with the starting fecal inocula. Because
Individual Core OTUs contained 95–98 % of the MBRA
sequences, we limited our analyses to these 144 OTUs.
In addition, we included those 28 OTUs that were abun-
dant in fecal samples (≥0.5 % of sequences) and were
not present in any of the individual core communities
(see Additional file 6 for a table listing the 28 OTUs
abundant in fecal samples and absent from individual
cores their abundances across fecal samples). Limiting
our analyses to these 172 OTUs greatly simplified the
amount of data while still representing the distribution
of ≥94.5 % of the sequences from every sample.
At the phylum level, MBRA communities exhibited
similar trends across replicate reactors and community
types (Fig. 5a). Sequences classified as Firmicutes were
the most abundant members of the community, ranging
from 44–70 %, followed by Bacteroidetes (18–32 %),
Proteobacteria (5–17 %), and Verrucomicrobia (3–8 %).
At this level of analyses, donors A and B MBRA com-
munities were also similar to their starting fecal inocula,
whereas donor C and the pool MBRA communities were
different. In the fecal inoculum for donor C, the ratio of
Firmicutes/Bacteroidetes sequences was higher (80 %
Firmicutes sequences/10 % Bacteroides sequences) than
the ratio in the fecal inoculum from either donor A
(61 % Firmicutes/27 % Bacteroidetes sequences) or
donor B (fecal inoculum in the fecal inoculum from
donor C (74 % Firmicutes/17 % Bacteroidetes). Growth
under MBRA cultivation conditions led to a decrease in
the ratio of Firmicutes/Bacteroides in reactor communities
seeded from donor C (mean ratio in MBRA communities
from donor C: 56 % Firmicutes/32 % Bacteroidetes), which
was more similar to that observed for MBRA communities
seeded with other fecal samples. The phylogenetic distribu-
tion of the pooled fecal inoculum was unexpected, with
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Fig. 4 Structure of MBRA core microbial communities. We designated
those OTUs that were present in ≥90 % of daily samples over
days 8–21 within each single reactor over time as members of
the “individual core.” Individual Core OTUs that were shared
across replicates of the same fecal type were designated members of
the “fecal type core” and those present in the core of all MBRA
communities were designated “all MBRA core.” We calculated the
mean percent abundance of OTUs (a) and sequences (b) in each type
of core from reactors on days 8–21 and plotted these values for each
replicate (1–3 for donors A, B, or C; 1–6 for pooled fecal donor). Each
core type includes those members also present in the broader core
type (i.e., individual core = individual core + fecal type core + all MBRA
core; fecal type core = fecal type core + all MBRA core)
Auchtung et al. Microbiome  (2015) 3:42 Page 7 of 15
only 2 % of sequences from Bacteroidetes, 81 % of
sequences from Firmicutes, 3 % of sequences from
Actinobacteria and 4 % of sequences from unclassified
bacteria. The levels of Bacteroidetes were 5–14-fold
lower than observed in any of the individual fecal
samples used to generate the pool; whereas the levels
of Actinobacteria and unclassified bacteria were 15–37-fold
and 3–15-fold higher, respectively, than any of the individ-
ual fecal samples used to generate the pool. (Levels of
Firmicutes (81 % of sequences), Proteobacteria (2 % of
sequences), and Verrucomicrobia (4 % of sequences) were
less than twofold different from at least one of the individ-
ual inocula.) This distribution could have been caused by
heterogeneity in the individual fecal samples used for prep-
aration of the pooled fecal sample and was not reflected on
pooled MBRA communities, which looked more similar to
other MBRA communities.
The variation between reactor communities and their
fecal inocula was more apparent when OTU distribu-
tions within specific phyla were examined (Fig. 5b–d);
these differences were primarily driven by members of
the Firmicutes and Proteobacteria (Fig. 5c, d; also see
Additional file 7 which presents Bray-Curtis similarities
for MBRA communities and their fecal inocula based
upon all OTUs as well as for OTUs partitioned by
phyla). The largest diversity across reactors was observed
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Fig. 5 Composition of MBRA core communities and comparison with fecal inocula. We analyzed the phylogenetic distribution of OTUs in the
individual core communities and compared this with the phylogenetic distribution of the original fecal inocula. To provide better representation
of the fecal inocula, those OTUs absent from the individual core communities that contributed at least 0.5 % of sequences to a fecal sample were
also included in our analyses. As in Fig. 4, data present is the mean abundance for each OTU across days 8–21. Following determination of
consensus classifications for each OTU (as described in Methods), we plotted the percent abundance of sequences in each phylum (a), genus
within Bacteroidetes (b), family within Firmicutes (c), and genus within Proteobacteria (d). If a consensus classification for the phylogenetic level
plotted could not be determined with confidence, the next highest classification assigned with ≥80 % is given preceded by the designation
“unclassified.” To simplify presentation of abundances in c, several families with low abundance across all samples were condensed in to the
designation “other Firmicutes”, which includes Clostridiales Incertae Sedis XIII, Eubacteriaceae, Incertae Sedis XI, unclassified Firmicutes, unclassified
Clostridia, unclassified Clostridiales, and Veillonellaceae
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in the Firmicutes; this phylum was represented by 144
OTUs (38 genera from 16 families). Although Proteo-
bacteria were less abundant members of the communi-
ties (4–20 % of sequences), they were represented by
seven different OTUs across six genera. In contrast,
OTUs within the Bacteroidetes phylum were primarily
members of the Bacteroides genus (Fig. 5b); all Verruco-
microbia sequences were from a single Akkermansia
OTU (classified using the Greengenes reference tax-
onomy as Akkermansia muciniphila). From these data,
we conclude that stable MBRA communities represent a
subset of their fecal inoculum. The percent of the initial
fecal inoculum present in core communities vary (from
as little as 25 % of sequences (15 % of OTUs) in donor B
communities to as much as 49 % of sequences (22 % of
OTUs) in donor A communities). The amount of overlap
observed was dependent upon the composition of the
community present in the initial inoculum and could re-
flect both differences in abundance of obligate anaerobes
that were lost prior to cultivation as well as differences in
ability to grow under our cultivation conditions.
Examination of core OTU dynamics over time in culture
Figure 5 presented the average abundance of taxa found
in ≥90 % of the samples collected on days 8–21 but did
not indicate how levels of these taxa varied over time.
To evaluate variation over time, we used heat maps to
visualize changes in abundance of core OTUs from the
starting fecal samples throughout time in culture (days
1–21). Variation in core OTUs from donor A are shown
in Fig. 6, whereas data from donors B and C are shown
in Additional files 8 and 9.
Analysis of the data from MBRA communities seeded
with donor A demonstrated three general trends. (1) Of
OTUs present in the fecal sample, ~20 % were lost or
decreased >5-fold during the first several days in culture
(e.g., Faecalibacterium, Roseburia, some Bacteroides,
and unclassified Lachnospiraceae; indicated OTUs are
identified by red text in Fig. 6). (2) Of OTUs, ~10 %
persisted in MBRAs from day-to-day at levels <3-fold
different than those observed in fecal samples (e.g.,
Flavonifracter, Akkermansia, Bacteroides #4, Ruminococ-
caceae #5; indicated OTUs are identified by blue text in
Fig. 6). (3) The remaining ~70 % of OTUs appear to in-
crease upon cultivation in at least one replicate tested.
Similar patterns of increase and loss of OTUs were seen
across MBRA communities inoculated from donors B and
C and the pooled fecal samples, although the organisms
impacted varied across the different fecal donors. For ex-
ample, Roseburia OTUs were lost from donor A and B
communities upon cultivation but persisted in communi-
ties inoculated with samples from donor C (see Additional
file 9, Roseburia OTU is in red type).
Included in the group of OTUs that increase upon culti-
vation were organisms classified as Enterobacteriaceae,
which constituted 2–18 % of total sequences found across
replicate reactors (mean abundance of two Enterobacteria-
ceae OTUs = 8 ± 5 % of sequences). Although many
Enterobacteriaceae are facultative organisms, these
organisms are unlikely to be respiring aerobically
because oxygen levels in the anaerobic chamber are
kept below 20 ppm. Organisms from the two Enterobacte-
riaceae OTUs could be respiring anaerobically, using alter-
native electron acceptors such as TMAO (known to
produced in MBRAs; JMA and RAB, unpublished results)
or fumarate (likely metabolic byproduct in reactor), or
could be fermenting available carbohydrates.
Conclusions
In this paper, we demonstrated that MBRAs can be used
to efficiently cultivate distinct communities from mul-
tiple fecal donors. Within the first week of cultivation,
distinct microbial communities capable of metabolizing
the available nutrients developed from the different
starting inocula. Adaptation to growth in culture shifted
the community structure. Although some community
members persisted at similar abundances to the fecal in-
ocula, other rare members of the inoculum increased in
abundance and a subset of the initial inoculum was lost.
This adaptation followed similar trends across replicates,
with stable communities obtained by day 8 in culture
(7 days with flow; ~21 turnovers).
Day-to-day variation within MBRA communities from
single reactors were similar to those observed in stable
mouse fecal communities. In contrast, replicate reactors
from the same fecal donor exhibited slightly higher vari-
ation than was observed between replicate mice. This vari-
ation appeared to partly be driven by differing abundances
of shared OTUs between replicates and could be indica-
tive of functional redundancy of organisms under the
MBRA cultivation conditions. This functional redundancy
could allow abundances of OTUs to fluctuate stochastic-
ally until stable communities are reached. Further work
will be needed to investigate functions of these different
communities, although we know that communities
formed from all three fecal donors as well as the pooled
fecal sample are capable of resisting colonization by
C. difficile in the absence of perturbation (JMA, CDR,
and RAB, unpublished results).
The composition and structure of MBRA communities
are similar to those reported in other in vitro models of
human fecal communities [27, 28, 39], although the
levels of Bacteroidetes are lower than are typically ob-
served in many models. One potential factor that might
lead to the lower levels of Bacteroidetes observed under
our culture conditions is the low concentrations of fer-
mentable carbohydrates present in our medium, which
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are a known substrate for Bacteroidetes (reviewed in
[40]). However, as the levels of Bacteroidetes detected
are similar to those present in the initial fecal inocula,
we do not consider the existing levels of Bacteroidetes in
MBRA communities to be of concern.
The choice of medium used to cultivate human fecal
communities can have a significant impact on the com-
munities that are formed (e.g., [40]). Although many of
the existing fecal bioreactor media share some reagents,
media can vary significantly in composition from one
experimental setup to the next (see Additional file 10, a
table comparing media composition from 11 different
bioreactor studies). When evaluating media for use in
our MBRA model, we compared different published
media recipes, with specific emphasis on those models
that supported dynamic interactions between human
fecal communities and C. difficile (i.e., [20]). We also
considered the results published by MacFarlane and col-
leagues [18], which demonstrated significant depletion
of fermentable carbohydrates in the third (distal colon
mimicking) vessel of their three-stage reactor model.
Based upon these observations as well as our own pre-
liminary studies with medium containing higher levels of
carbohydrates, we chose to use a medium low in glucose
(0.004 %, 220 μM), disaccharides (0.015 % (440 μM)
each of maltose and cellobiose), and complex carbohy-
drates (inulin, 0.02 %; arabinogalactan, 0.01 %), in an at-
tempt to more closely simulate conditions that might be
encountered in the distal colon. (Although glucose and
maltose are primarily absorbed in the small intestine,
inulin, arabinogalacton, and cellobiose have been shown
to be primarily fermented in the colon [41–43]). We also
included Tween 80, a reagent commonly added to bio-
reactor medium (see Additional file 10, a table compar-
ing media composition from 11 different bioreactor
studies). Tween 80 can be used as a source of unsatur-
ated fatty acids by several Lactobacillus species and has
been shown to enhance growth [44] and protect from
bile acid stress [45].
Although our model does not include a surrogate for
mucosal surface as in M-SHIME, our phylogenetic dis-
tributions were more similar to the luminal contents of
the M-SHIME model than to the original L-SHIME
model [27, 39], with Firmicutes composing 44–70 % of
the population. Further, we found that sequences of the
known mucin-degrader Akkermansia muciniphila [46]
were present in modest abundance in all stable reactor
communities (~5 % of sequences). Further work will be
needed to determine how MBRA cultivation conditions
are supporting growth of Akkermansia in the absence of
mucin.
One limitation to the communities cultivated in our
MBRA is our inability to cultivate Faecalibacterium
prausnitzii (11–36 % of sequences from fecal inocula) as
well as several other less abundant Clostridiales species.
Work from the Flint laboratory has demonstrated that
both F. prausnitzii as well as certain members of Clos-
tridium cluster XIVa require acetic acid as a cofactor for
metabolism (reviewed in [40]), which is not present in
our medium and is unlikely to be produced until a ma-
ture community is established. Further, F. prausnitzii
does not grow well in medium with protein as the pri-
mary dietary substrate. Therefore, we may need to con-
sider additional modifications to the medium to include
a higher concentration of fermentable carbohydrates as
well as a potential source of acetate during outgrowth to
facilitate cultivation of F. prausnitzii.
A second limitation of our MBRA model is the inabil-
ity to study interactions with host cells, both to assess
how the microbiome impacts the host and to determine
feedback of the host upon the microbiome. Although
this limitation can be overcome by coupling MBRA
studies with follow-up studies in humanized microbiota
mice [29], it would also be beneficial to begin to inter-
face MBRA communities directly with host cells in vitro.
Platforms for interfacing microbial communities with
tissue culture cells have been described [47, 48], includ-
ing the HMI model for SHIME [47]. We anticipate that
the relatively simple MBRA design could make it ideal
for coupling with host cells, either individual cell lines
or human intestinal enteroids or organoids [49, 50],
thereby facilitating higher-throughput in vitro studies of
microbiome/host interactions.
Methods
Fecal sample collection, preparation, and MBRA operation
Fecal samples from three healthy individuals were col-
lected into sterile containers, sealed, and transferred to
(See figure on previous page.)
Fig. 6 Analysis of abundance of core OTUs identified in Donor A MBRA communities as a function of time in culture. We determined the
abundance of the 94 OTUs that were identified as present in individual core communities for MBRAs inoculated with fecal donor A or were
abundant in the donor A fecal sample as described in Fig. 5 and plotted the abundance of these OTUs in the fecal sample and over time in
culture (days 1–21) across the three replicate reactors. Data are organized by phylum, with the lowest taxonomic classification assigned with
confidence listed on the left hand side. Magnitude of shading is indicated on the figure and ranges from 1 to ≥256 sequences for Firmicutes,
Bacteroidetes, and Proteobacteria. Abundance of Actinobacteria sequences range from 1 to 4 sequences; whereas the abundance of the single
Verrucomicrobia OTU range from 1 to ≥1024 sequences. The line at the left end of the x-axis indicates the fecal sample. The triangles demarcate
time in cultures for the different replicate reactors, with the first time point present on the left side for each replicate. Similar heat maps for donor
B and donor C are available in Additional files 8 and 9
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an anaerobic chamber within 1 h of defecation. Samples
were manually homogenized and subdivided into sterile
vials, which were stored at −80 °C until use. Prior to
MBRA inoculation, fecal samples were resuspended at
25 %w/v in anaerobic phosphate buffered saline in the
anaerobic chamber, vortexed for 5 min, and centrifuged at
201×g. For the pooled sample, equal amounts of each fecal
sample (by mass) were combined prior to vortexing.
In order to analyze the impact of freezing upon MBRA
cultivation, one fecal donor (donor A) provided a second
sample ~3 months post initial donation (donor A2). This
sample was collected and transferred to the anaerobic
chamber within 1 h of defecation. Following manual
homogenization and subdivision into sterile vials, a por-
tion of the sample was flash frozen in liquid nitrogen for
45 min (frozen), whereas the other sample was main-
tained in the anaerobic chamber until inoculation. Both
fresh and frozen samples were then inoculated into trip-
licate reactors and analyzed as described below. Analysis
of this data revealed that there was little impact on com-
munities cultivated from frozen samples compared to
freshly voided samples (see Additional file 11 for an
NMDS ordination of the Bray-Curtis dissimilarities
between these different samples as well tests of community
similarity and dispersion).
MBRA were prepared for use as previously described
[29] and inoculated with 4 ml of fecal slurry. Bioreactor
medium was prepared as described [29], except that 1 g/
L of taurocholic acid was replaced with 0.5 g/L of bovine
bile, which was added prior to autoclaving. There were
multiple reasons for substituting bovine bile for tauro-
cholate. (1) Bovine bile is a complex mixture of bile salts
as well as other constituents of bile (e.g., fatty acids,
cholesterol, inorganic salts) and is more commonly used
in medium for cultivation of human fecal communities
than taurocholate alone. (2) Taurocholate was originally
included in our medium to promote germination of C.
difficile spores; subsequent studies have shown that bo-
vine bile is sufficient to support germination under our
reactor conditions (Auchtung and Britton, unpublished
results). (3) Bovine bile is significantly less expensive
than taurocholate (>10-fold lower cost).
After inoculation, fecal bacteria were allowed to equili-
brate for 16–18 h prior to the initiation of flow. After
equilibration, a 1-ml sample was removed (day 1 sample)
and flow commenced at 1.875 ml/h (8-h retention time).
Reactors were then sampled daily for 20 additional days
(days 2–21). Cells were pelleted from samples by centri-
fugation at 21,000×g. Supernatants were discarded, and
pellets were stored at −80 °C until further processed.
Ethics, consent, and permissions
Fecal sample collection was reviewed and approved by
the Institutional Review Board from Michigan State
University. All individuals donating samples provided in-
formed consent prior to donation.
Sample preparation and sequencing
Previously, we had success amplifying C. difficile genes
from samples that had been disrupted by bead beating
without further purification [29]. Further, Flores et al.
had also reported success with a direct amplification ap-
proach for higher-throughput analysis of 16S rRNA gene
content from microbial samples [38]. We were interested
in pursuing direct amplification in order to significantly
reduce sample preparation time and costs. Therefore, we
performed preliminary studies to compare sequences ob-
tained from replicate samples prepared by direct amplifi-
cation to those that obtained from samples from which
DNA was extracted prior to amplification. These studies,
which demonstrated robust reproducibility between
duplicate samples prepared by direct amplification, are
described in detail in Additional file 12: Supplementary
Methods and Additional files 13, 14, and 15 (which
present the data described in additional file 12).
We resuspended our samples in a 0.5-ml sterile water
and transferred them to bead beating tubes. (Our bead
beating tubes were prepared by transferring ~200 μl
0.1 mm silica beads (Biospec Products) and 100 μl sterile
water into 2-ml screw cap tubes and autoclaving these
tubes for at least 20 min prior to use.) Samples were ho-
mogenized in a mini-beadbeater-96 (Biospec Products)
for 2 min, centrifuged at 8000×g for 1 min, then super-
natants were transferred to new tubes, which were
stored at -20 °C prior to amplification.
The V4 region of the 16S rRNA gene was amplified
with primers F515/R806, using a dual-indexing approach
(4 forward primer; 96 reverse primer). The 96-indexed
R806 primers used were previously described ([51];
806rbc0-806rbc96). The indexed F515 primers were es-
sentially as described [37], except that we generated four
barcodes that balanced the nucleotide composition at each
position (ATCGATGG, TCACGACA, GGTATCTC, and
CAGTCGAT) in place of those described by Kozich et al.
Prior to PCR amplification, samples were diluted 1:100.
The final 25-μl PCR reactions contained 4 μl of diluted
template, 1× Phusion High Fidelity Buffer (New England
Biolabs), 200 μM dNTPs (Promega), 10 nM primers and
0.225 units of Phusion DNA Polymerase (New England
Biolabs). The amplification cycle consisted of an initial de-
naturation at 98 °C for 30 s, followed by 30 cycles of 10 s
at 98 °C, 20 s at 51 °C, and 1 min at 72 °C. Successful
amplification was verified by agarose gel electrophoresis of
products. If samples failed to amplify, amplification with a
new 1:100 dilution was attempted. If re-amplification
failed, amplification was attempted with a 1:10 dilution of
sample. Because we were unable to obtain amplification
from the fecal slurries from donor A, B, C, or the pooled
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sample at these dilutions, we extracted DNA as previously
described [29] prior to amplification and used 4 μl of
10 ng/μl DNA in PCR reactions as described above. As
discussed in more detail in Additional file 12, which com-
pares extracted and amplified fecal samples to MBRA
communities, comparing MBRA communities that were
directly amplified to extracted fecal samples is one poten-
tial source of variation between our MBRA communities
and fecal samples. However, sample preparation method
prior to sequencing is likely not the primary source of
variation between fecal and reactor communities as
differences in sample preparation method in our con-
trol studies resulted in Bray-Curtis similarities of
0.64–0.78 (see Additional file 13 for the impact of
sample preparation on Bray-Curtis and Sorenson
similarity measures) as compared to the Bray-Curtis
similarities observed between fecal and MBRA samples of
0.08–0.40 (mean = 0.17). Further, we were able to success-
fully amplify community DNA from the donor A2-fresh
and frozen samples described in Additional file 11 without
DNA extraction, yet observed similar levels of dissimilarity
between these fecal inocula and their respective MBRA
communities.
Three independent PCR replicates were pooled and
cleaned up using AMPure beads as previously described
[29]. Concentrations of purified DNA samples were de-
termined with QuantIT (Life Technologies). Purified
samples were pooled at equimolar ratios, and the quality
of the pooled DNA was assessed by analysis on a Bioanaly-
zer High Sensitivity DNA Kit (Agilent). Prior to sequencing,
DNA concentration was determined by amplicon-specific
qPCR (Illumina Complete Kit, Kapa Biosystems). Samples
were mixed with 3–7 % phiX DNA, and sequencing was
performed at the Research Support Technology Facility
(RTSF) with a MiSeq v2 Reagent kit on an Illumina MiSeq
running MisSeq Control Software version 2.3.0.3. Sequen-
cing was completed in two separate MiSeq runs.
Analysis of sequence data
Sequences were analyzed in Mothur versions 1.31, 1.33,
and 1.34 essentially as described [37]. MiSEQ SOP ver-
sion 28 March 2013 was used as a template (http://
www.mothur.org/wiki/MiSeq_SOP). Forward and re-
verse reads were paired, quality-trimmed, aligned to a
Silva 16S rRNA gene reference database, trimmed to en-
sure overlap to the same region of the 16S rRNA gene
(position 534-786 of Escherichia coli 16S rRNA gene),
and pre-clustered to clusters with ≥99 % identity as de-
scribed. Potential chimeric sequences were identified with
the mothur-implementation of uchime and removed. Se-
quences were then classified with the Bayesian classifier in
mothur, using the mothur-formatted ribosomal database
project version 9 database from August 2013. Sequences
were clustered from a distance matrix using the average-
neighbor algorithm in mothur. Taxonomic assignments
for each OTU were determined in mothur and are the
majority consensus taxonomic assignments for each se-
quence within the OTU.
The mean and SD of inverse Simpson diversity, Simpson
evenness, Shannon diversity, and number of observed spe-
cies were calculated in mothur from data randomly sub-
sampled to 10,000 sequences over 100 iterations. A single
iteration of subsampling to 10,000 sequences was used for
determination of Bray-Curtis and Sorenson dissimilarity
measures. Bray-Curtis and Sorenson dissimilarity values
were calculated on untransformed data, both in mothur
and with vegan package of R ([52]; Sorenson = Binary
Bray-Curtis); when presented as similarity values,
Bray-Curtis and Sorenson similarities = 1-dissimilarities.
Non-metric multi-dimensional scaling was also performed
in mothur and in vegan using the metaMDS function.
NMDS Plots were generated in R from the metaMDS
results. ANOSIM, PERMANOVA (ADONIS), and
Betadispersion were calculated with the vegan package
of R. Heatmaps were generated using the phyloseq
implementation of NeatMap [53]. All other plots were
generated in Graph Pad Prism v.6.
For the mouse stability studies, paired Illumina
reads were downloaded from the Schloss lab website
(http://www.mothur.org/MiSeqDevelopmentData.html).
Sequences were processed through mothur as described
above, then subsampled to 3500 sequences prior to
calculation of beta-diversity measures. Data were from
three female (F3, F4, and F7) and three male (M2,
M5, and M6) mice on days 1–9 (unstable communities)
and days 141–150 (stable communities).
Availability of supporting data
The sequence data described in this manuscript is can
be accessed from the short read archive at NCBI
(SRP059604).
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Additional file 1: Additional measures of MBRA diversity. Plots of
Shannon Diversity and the number of OTUs containing at least one
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Additional file 2: Stabilization of MBRA communities. Plot of
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reactors.
Additional file 3: Similarity between replicate reactors increases
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replicate reactors over time in cultivation.
Additional file 4: Mean Bray-Curtis and Sorenson dissimilarities for
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Additional file 5: Relative abundance of all MBRA core OTUs across
stable reactors (days 8–21; mean ± SD). Table providing the mean
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stable MBRA core communities. Table providing the percent
abundance of abundant (>0.5 %) fecal OTUs absent from stable MBRA
core communities.
Additional file 7: Bray-Curtis similarities between MBRA
communities and their fecal samples determined from OTUs of
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as by OTUs partitioned by phyla.
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fecal donor B MBRA communities as a function of time in culture.
Heatmap presenting abundance of OTUs that were identified as present
in individual core communities for MBRAs inoculated with donor B as
well as abundant in the donor B fecal sample.
Additional file 9: Analysis of abundance of core OTUs identified in
fecal donor C MBRA communities as a function of time in culture.
Heatmap presenting abundance of OTUs that were identified as present
in individual core communities for MBRAs inoculated with donor C as
well as OTUs abundant in the donor C fecal sample.
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in 1 L of medium. Table comparing reagent concentrations described
for media used for cultivation of complex fecal communities from 11
different sources.
Additional file 11: Fresh and frozen fecal samples form similar
communities in MBRA. NMDS plot and ANOSIM, PERMANOVA, and
ANOVA of β-dispersion statistics of Bray-Curtis dissimilarities calculated
from OTUs present in MBRA communities seeded with donor A2-fresh
and donor A2-frozen fecal samples.
Additional file 12: Supplemental methods. Supplemental methods
describing methods used to compare direct sequencing approach to
DNA extraction and amplification as well as identification of potential
sequencing contaminants from negative control samples.
Additional file 13: Impact of sample preparation method on
Bray-Curtis and Sorenson similarities in replicate samples. Table
providing differences in Bray-Curtis and Sorenson similarities in replicate
samples prepared with different extraction methods.
Additional file 14: Distribution of sequences in shared OTUs across
replicate samples prepared by different methods. A table providing
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